Lidocaine and methylprednisolone in management of herpes zoster and post-herpetic neuralgia.
Gintautas
J
J
Brookdale University Hospital and Medical Center, New York, USA. gintautasj@aol.com
Abraham
Y
Y
Doss
N W
NW
Ghobriel
A
A
Kashem
A
A
Fogler
R J
RJ
D000368:Aged; D015360:Analgesia, Epidural; D000779:Anesthetics, Local / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006562:Herpes Zoster / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy* / Q000209:etiology*; D010147:Pain Measurement; D012189:Retrospective Studies
D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D008012:Lidocaine; D008775:Methylprednisolone